Of rodents and men: species-specific glucose regulation and type 2 diabetes research

P Charukeshi Chandrasekera1, John J Pippin

  • 1Physicians Committee for Responsible Medicine, Washington DC, USA.

ALTEX
|November 26, 2013
PubMed

Insights

Rodent models for type 2 diabetes (T2DM) show significant species-specific differences compared to humans. Developing human-based research strategies is crucial for advancing T2DM epidemic control.

Area of Science:

  • Endocrinology and Metabolism
  • Translational Medicine
  • Biomedical Research

Background:

  • Type 2 diabetes mellitus (T2DM) is a global epidemic, necessitating effective research models.
  • Rodent models are extensively used for T2DM research, generating substantial scientific literature.
  • Despite extensive research, human T2DM pathogenesis and prevention strategies remain incompletely understood.

Purpose of the Study:

  • To investigate the reasons for the translational discrepancy between rodent models and human type 2 diabetes mellitus.
  • To analyze experimental evidence from rodent models of T2DM in comparison to human data.
  • To highlight the need for human-based research strategies in T2DM studies.

Main Methods:

  • Review and analysis of experimental evidence from rodent models of T2DM.
  • Comparative analysis of glucose regulation mechanisms between rodent models and human data.
  • Examination of species-specific differences at multiple biological levels.

Main Results:

  • Significant species-specific differences exist between rodent models and humans in glucose regulation.
  • Discrepancies were observed at the levels of gene/protein expression, cellular signaling, and organ function.
  • An immutable translational gap is evident due to these fundamental species-specific barriers.

Conclusions:

  • Rodent models present significant limitations for fully understanding human T2DM pathogenesis.
  • The translational gap hinders the development of effective pharmacotherapeutics and prevention strategies for T2DM.
  • There is an urgent need to prioritize and develop human-based research approaches to combat the T2DM epidemic.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
57
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
121
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
32